143 related articles for article (PubMed ID: 2306688)
21. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.
Lee GW; Go SI; Kim SH; Hong J; Kim YR; Oh S; Kim SY; Do YR; Lee H; Lee SI; Bae SH; Oh SY; Song MK; Lee WS; Lee B; Kim JS; Kim MK; Kang HJ; Ahn JS; Yhim HY; Kim HJ; Kim SJ; Kim WS; Suh C;
Leuk Lymphoma; 2015 Apr; 56(4):1020-6. PubMed ID: 25039351
[TBL] [Abstract][Full Text] [Related]
23. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
26. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536
[TBL] [Abstract][Full Text] [Related]
27. Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification.
Hatta C; Ogasawara H; Okita J; Kubota A; Ishida M; Sakagami M
Auris Nasus Larynx; 2001 Jan; 28(1):55-60. PubMed ID: 11137364
[TBL] [Abstract][Full Text] [Related]
28. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
[TBL] [Abstract][Full Text] [Related]
29. B-cell lymphoma with extensive cutaneous involvement presenting to the ENT surgeon.
Hughes RG; Morgan DW
J Laryngol Otol; 1998 Feb; 112(2):186-8. PubMed ID: 9578884
[No Abstract] [Full Text] [Related]
30. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital].
Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R
Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940
[No Abstract] [Full Text] [Related]
31. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses.
Robbins KT; Kong JS; Fuller LM; Goepfert H
J Otolaryngol; 1985 Feb; 14(1):7-13. PubMed ID: 4068097
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
Ma HH; Qian LT; Pan HF; Yang L; Zhang HY; Wang ZH; Ma J; Zhao YF; Gao J; Wu AD
Med Oncol; 2010 Sep; 27(3):798-806. PubMed ID: 19685292
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphomas of the sinonasal region: histologic subtypes and their clinicopathologic features.
Frierson HF; Mills SE; Innes DJ
Am J Clin Pathol; 1984 Jun; 81(6):721-7. PubMed ID: 6547270
[TBL] [Abstract][Full Text] [Related]
35. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
36. [Non-Hodgkin's lymphoma in children. 10-year experience with the IGG-NHL-74 protocol at the G. Gaslini Institute].
Comelli A; De Bernardi B; Dini G; Tomà P; Rizzo A
Minerva Pediatr; 1985 Sep; 37(17):611-3. PubMed ID: 4079879
[No Abstract] [Full Text] [Related]
37. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
38. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
[TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
40. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]